BioCentury | Jan 27, 2021
Management Tracks

Novartis’ chief digital officer stepping down; plus moves at Taysha, Roivant, Faze and more

...CMO. Medori was most recently CMO of Affiris AG. Bernard Courtieu joined theranostic and genomics company OncoDNA S.A....
BioCentury | Mar 21, 2017
Company News

Management tracks

...head of innovative medicines for respiratory and inflammation at AstraZeneca plc (LSE:AZN; NYSE:AZN). Cancer company OncoDNA S.A....
BioCentury | Sep 5, 2016
Financial News

OncoDNA completes venture financing

OncoDNA S.A. , Gosselies, Belgium Business: Diagnostic, Supply/Service Date completed: 2016-09-02 Type: Venture financing Raised: EUR7.7 million ($8.7 million) Investors: Institute of Pathology and Genetics; Invest4OncoDNA; Sambrinvest; Vinsovier; Sofinim-Ackermans van Haaren; Societe Regionale d’Investissement de Wallonie...
Items per page:
1 - 3 of 3
BioCentury | Jan 27, 2021
Management Tracks

Novartis’ chief digital officer stepping down; plus moves at Taysha, Roivant, Faze and more

...CMO. Medori was most recently CMO of Affiris AG. Bernard Courtieu joined theranostic and genomics company OncoDNA S.A....
BioCentury | Mar 21, 2017
Company News

Management tracks

...head of innovative medicines for respiratory and inflammation at AstraZeneca plc (LSE:AZN; NYSE:AZN). Cancer company OncoDNA S.A....
BioCentury | Sep 5, 2016
Financial News

OncoDNA completes venture financing

OncoDNA S.A. , Gosselies, Belgium Business: Diagnostic, Supply/Service Date completed: 2016-09-02 Type: Venture financing Raised: EUR7.7 million ($8.7 million) Investors: Institute of Pathology and Genetics; Invest4OncoDNA; Sambrinvest; Vinsovier; Sofinim-Ackermans van Haaren; Societe Regionale d’Investissement de Wallonie...
Items per page:
1 - 3 of 3